These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24857754)

  • 21. Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.
    Huang NL; Chiang SH; Hsueh CH; Liang YJ; Chen YJ; Lai LP
    Int J Cardiol; 2009 May; 134(2):169-75. PubMed ID: 18597869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells.
    Aw DK; Sinha RA; Xie SY; Yen PM
    Biochem Biophys Res Commun; 2014 May; 447(4):569-73. PubMed ID: 24735537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing.
    Dixon D; Edmonds M
    Drugs; 2021 Jan; 81(1):29-56. PubMed ID: 33382445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of AMP-activated protein kinase: prospects for computer-aided drug design.
    Kim J; Yang G; Ha J
    Expert Opin Drug Discov; 2017 Jan; 12(1):47-59. PubMed ID: 27797589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMP-activated protein kinase: a target for old drugs against diabetes and cancer.
    Russo GL; Russo M; Ungaro P
    Biochem Pharmacol; 2013 Aug; 86(3):339-50. PubMed ID: 23747347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of surgical debridement in healing of diabetic foot ulcers.
    Lebrun E; Tomic-Canic M; Kirsner RS
    Wound Repair Regen; 2010; 18(5):433-8. PubMed ID: 20840517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.
    Wang XF; Zhang JY; Li L; Zhao XY; Tao HL; Zhang L
    Clin Exp Pharmacol Physiol; 2011 Feb; 38(2):94-101. PubMed ID: 21143620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders.
    Antonioli L; Colucci R; Pellegrini C; Giustarini G; Sacco D; Tirotta E; Caputi V; Marsilio I; Giron MC; Németh ZH; Blandizzi C; Fornai M
    Expert Opin Ther Targets; 2016; 20(2):179-91. PubMed ID: 26414111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenine accelerated the diabetic wound healing by PPAR delta and angiogenic regulation.
    Leu JG; Chiang MH; Chen CY; Lin JT; Chen HM; Chen YL; Liang YJ
    Eur J Pharmacol; 2018 Jan; 818():569-577. PubMed ID: 29162431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy.
    Morley S; Griffiths J; Philips G; Moseley H; O'Grady C; Mellish K; Lankester CL; Faris B; Young RJ; Brown SB; Rhodes LE
    Br J Dermatol; 2013 Mar; 168(3):617-24. PubMed ID: 23066973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of a Common Antibiotics Doxycycline on Non-Healing Chronic Wound.
    Xu DH; Zhu Z; Fang Y
    Curr Pharm Biotechnol; 2017; 18(5):360-364. PubMed ID: 28524000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with topical nitroglycerine may promote the healing process of diabetic foot ulcers.
    Mikaili P; Moloudizargari M; Aghajanshakeri S
    Med Hypotheses; 2014 Aug; 83(2):172-4. PubMed ID: 24880867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMPK in microvascular complications of diabetes and the beneficial effects of AMPK activators from plants.
    Shrikanth CB; Nandini CD
    Phytomedicine; 2020 Jul; 73():152808. PubMed ID: 30935723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
    Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMPK activators for the prevention and treatment of neurodegenerative diseases.
    Neumann NR; Thompson DC; Vasiliou V
    Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1199-1210. PubMed ID: 34632898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AMP-activated protein kinase: a target for drugs both ancient and modern.
    Hardie DG; Ross FA; Hawley SA
    Chem Biol; 2012 Oct; 19(10):1222-36. PubMed ID: 23102217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach.
    Huang T; Sun J; Zhou S; Gao J; Liu Y
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28665353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metformin–new potential medicine in pain treatment?].
    Kiałka M; Doroszewska K; Janeczko M; Milewicz T
    Przegl Lek; 2017; 74(2):81-3. PubMed ID: 29694764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in biomaterials for the treatment of diabetic foot ulcers.
    Kasiewicz LN; Whitehead KA
    Biomater Sci; 2017 Sep; 5(10):1962-1975. PubMed ID: 28829074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?
    Li T; Jiang S; Yang Z; Ma Z; Yi W; Wang D; Yang Y
    Cell Mol Life Sci; 2017 Apr; 74(8):1413-1429. PubMed ID: 27815596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.